Opiant Pharmaceuticals Announces Publication of New Pre-Clinical Data Supporting Potential of OPNT005 as a …  Markets InsiderOpiant Pharmaceuticals (OPNT) Rating Lowered to Hold at ValuEngine  StockNewsTimesFull coverage http://markets.businessinsider.com/news/stocks/Opiant-Pharmaceuticals-Announces-Publication-of-New-Pre-Clinical-Data-Supporting-Potential-of-OPNT005-as-a-Heroin-Vaccine-1011616549